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TTF1: thyroid transcription factor 1INTRODUCTION
Breast carcinoma, the most common malignancy
inwomen, is rarely diagnosed inmen.Approximately
1,910 new cases of breast carcinoma in men are
reported annually1 compared with more than
230,000 new cases in women.2 Most male cases
(90%) are of the invasive ductal subtype.3 The lifetime
risk of breast cancer for men in the general popula-
tion is 0.1%.1 Genetic predisposition significantly
heightens this risk, with mutations in BRCA2
increasing the lifetime risk to an estimated 5% to
10%.1 Inactivation of other tumor suppressors,
including BRCA1, PTEN, p53, and CHEK2, is also
found to confer an increased risk in men.1,3
Congenital disorders such as Klinefelter’s syndrome
contribute to at least 3% of the incidence of all male
breast cancer.1
We report a 77-year-old man presenting with a
painful right axillary mass diagnosed as metastatic
carcinoma of unknown primary. Despite multiple
treatment modalities, his disease progressed to the
brain, lungs, and skin as carcinoma en cuirasse.
Histopathologic diagnosis at autopsy was pleomor-
phic lobular carcinoma (PLC), an uncommon subtype
of breast cancer that is reported rarely in men.CASE REPORT
A 77-year-old man with a 50-pack-year smoking
history presented to our institution with an
enlarging, painful, right axillary mass. Fine-needle
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Histology testing found infiltrates of tumor nodules
with large, pleomorphic, poorly differentiated
epithelial cells extending into the surrounding fibro-
fatty tissue and lymphatics. Immunohistochemical
stains were positive for cytokeratin 7 and epithelial-
membrane antigen but negative for lymphocytic
markers (CD3, CD20, CD45), caudal type homeobox
gene 2 (CTH2), prostate-specific antigen (PSA), pro-
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Fig 2. Carcinoma en cuirasse secondary to pleomorphic lobular carcinoma of the breast. A,
The anterior chest wall, shoulder and right neck were encased in an erythematous, sclerotic
plaque, composed of approximately 0.5- to 1.0-cm firm papules, sparing the nipples. B, The
affected area also demonstrated a peau d’orange appearance with papulonodular margins.
Fig 3. High-power view shows atypical cells infiltrating in
a single-file pattern and abundant mucin deposition.
(Hematoxylin-eosin stain.)
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tomography (CT) scan of the chest found right
axillary and subpectoral adenopathy (Fig 1).
Positron emission tomography/CT scan found fluo-
rodeoxyglucose uptake in the right neck and chest
consistent with a neoplastic process.
The patient received multiple treatment modal-
ities, complicated by intermittent periods of poor
follow-up. Therapy included 5 cycles of carboplatin
and paclitaxel, 1 cycle of docetaxel, and palliative
radiotherapy. Fourteen months after initiating
treatment, a workup for dyspnea found malignant
effusion and brain metastases.
The patient was referred to hospice care; how-
ever, 3 months later, he presented with worsening
dyspnea. At this time, the right anterior chest wall
and neck were encased in an erythematous, sclerotic
plaque, composed of approximately 0.5- to 1.0-cm
firm papules, sparing the nipples (Fig 2, A). The
affected skin showed a peau d’orange appearance
with peripheral papulonodules and pseudovesicular
papules (Fig 2,B). The ipsilateral armwas exquisitely
tender with 4 1 pitting edema. CT scan found
complete collapse of the right lung with massive
pleural effusion; irregular, nodular, soft-tissue den-
sities were seen on the right anterior chest wall,
suspected to be the primary source. On brain mag-
netic resonance imaging, metastases had enlarged
and several new enhancing lesions were noted. Skin
biopsy found epidermal spongiosis with interstitial
fibrosis and thickened collagen bundles in the
dermis. Atypical cells infiltrating in a single file
pattern and abundant mucin deposition were found
(Fig 3). Immunohistochemistry was positive for
cytokeratin 7, and negative for cytokeratin 20,
TTF1, PSA, and CTH2, consistent with carcinoma.
Shortly thereafter, he died of a septic episode.At autopsy, the pericardial sac and pleura were
studdedwithwhite,firmnodules, and the skinshowed
metastatic carcinoma. Immunohistochemistry was
positive for pan cytokeratin, gross cystic disease fluid
protein 15, and mammaglobin and negative for
E-cadherin, ER, PR, and HER2/neu. The final patho-
logic diagnosiswas pleomorphic lobular carcinoma of
the breast, apocrine subtype, with metastases to skin,
brain, lungs, pleura, pericardium, diaphragm, chest
wall muscle, and lymph nodes.DISCUSSION
Invasive lobular carcinoma of the male breast is
rare, owing to the absence of lobules and acini inmale
breast tissue, representing only 1% of male breast
cancer.3 PLC is an uncommon highly aggressive
subtype, with few reported cases in men.4 PLC often
presents at an advanced stage, is likely to be larger
with more positive lymph nodes at time of diagnosis,
and carries an increased risk of lymphovascular
invasion and distant metastases.5 Cytologically, it is
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increased hyperchromasia, frequent mitotic figures,
and eosinophilic cytoplasm.5,6 Histologically, PLC
shows loss of E-cadherin expression and no
expression of ER and PR and has a high rate of
HER2/neu gene amplification.6 However, HER2 gene
amplification appears to be variable in male PLC
cases.4 In this patient, the apocrine subtype was
suspected, associated with significantly more
genomic alterations than the nonapocrine type.6
Breast cancer is a common malignancy to metas-
tasize to the skin. Carcinoma en cuirasse, a distinct
clinicopathologic type of cutaneous metastasis, was
coined by Velpeau in 1838 to describe a thick,
leathery breast plate of cancer involving the chest
and abdominal wall.7 Primary carcinoma en cuirasse
is rare, presenting as extensive skin involvement in
the setting of untreated malignancy; secondary
disease is more common, presenting as a local chest
wall recurrence after mastectomy, radiation, or
chemotherapy.8 In this case, carcinoma en cuirasse
was caused by occult breast cancer.
The pathogenesis of carcinoma en cuirasse
remains largely unknown. It is speculated that
pleiotrophin, an extracellular signaling molecule,
acts as a multifunctional tumor promoter leading to
rapid tumor growth and progression to the scirrhous
subtype of invasive carcinoma.9 Clinically, this
carcinoma begins as scattered, firm, papulonodules
overlying an erythematous skin surface progressing
to brawny hardness, which eventually coalesces into
a sclerodermoid plaque.7,8 Histologically, there is
extensive dermal fibrosis with single filing of atypical
malignant cells; tumors cells may be overlooked
because of similarity in appearance to fibroblasts.10
Treatment options are limited. Because the tumor
cells cause extensive reactive fibrosis and decreasedvascularity, chemotherapeutic agents may be unable
to obtain tumoricidal concentrations locally.8,10 The
goal is palliative; local irradiation, skin graft, and
nonsteroidal anti-inflammatory drug therapy have
shown some success.
To our knowledge, this is the first reported case of
carcinoma en cuirasse caused by male breast cancer,
and the fifth reported case of PLC in a man. Our case
serves to highlight the rapid progression of this rare
malignancy and the challenges associated with early
detection, diagnosis, and treatment.REFERENCES
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